143 related articles for article (PubMed ID: 10520378)
1. [Inhibition of 18F-FDG uptake in glioblastoma cells by FDG and glucose].
Oehr P; Ruhlmann J; Kozak B; Brock H; Thieme D; Rink H
Acta Med Austriaca; 1999; 26(3):101-3. PubMed ID: 10520378
[TBL] [Abstract][Full Text] [Related]
2. Glucose transporter protein-independent tumor cell accumulation of fluorine-18-AFDG, a lipophilic fluorine-18-FDG analog.
Waki A; Fujibayashi Y; Magata Y; Yokoyama A; Sadato N; Tsuchida T; Ishii Y; Yonekura Y
J Nucl Med; 1998 Feb; 39(2):245-50. PubMed ID: 9476929
[TBL] [Abstract][Full Text] [Related]
3. Glut-1 and hexokinase expression: relationship with 2-fluoro-2-deoxy-D-glucose uptake in A431 and T47D cells in culture.
Aloj L; Caracó C; Jagoda E; Eckelman WC; Neumann RD
Cancer Res; 1999 Sep; 59(18):4709-14. PubMed ID: 10493529
[TBL] [Abstract][Full Text] [Related]
4. Impact of animal handling on the results of 18F-FDG PET studies in mice.
Fueger BJ; Czernin J; Hildebrandt I; Tran C; Halpern BS; Stout D; Phelps ME; Weber WA
J Nucl Med; 2006 Jun; 47(6):999-1006. PubMed ID: 16741310
[TBL] [Abstract][Full Text] [Related]
5. Tumor blood flow measured by PET dynamic imaging of first-pass 18F-FDG uptake: a comparison with 15O-labeled water-measured blood flow.
Mullani NA; Herbst RS; O'Neil RG; Gould KL; Barron BJ; Abbruzzese JL
J Nucl Med; 2008 Apr; 49(4):517-23. PubMed ID: 18344436
[TBL] [Abstract][Full Text] [Related]
6. A cell-culture reactor for the on-line evaluation of radiopharmaceuticals: evaluation of the lumped constant of FDG in human glioma cells.
Noll T; Mühlensiepen H; Engels R; Hamacher K; Papaspyrou M; Langen KJ; Biselli M
J Nucl Med; 2000 Mar; 41(3):556-64. PubMed ID: 10716332
[TBL] [Abstract][Full Text] [Related]
7. Investigation of transport mechanism and uptake kinetics of O-(2-[18F]fluoroethyl)-L-tyrosine in vitro and in vivo.
Heiss P; Mayer S; Herz M; Wester HJ; Schwaiger M; Senekowitsch-Schmidtke R
J Nucl Med; 1999 Aug; 40(8):1367-73. PubMed ID: 10450690
[TBL] [Abstract][Full Text] [Related]
8. [Toxicity and radiation dosage of 2-(18F)-2-desoxy-D-glucose in positron emission tomography].
Ruhlmann J; Oehr P; Bender H; Kozak B; Willkomm P; Bechtold V; Lind P; Biersack HJ
Acta Med Austriaca; 1998; 25(1):1-6. PubMed ID: 9576017
[TBL] [Abstract][Full Text] [Related]
9. Comparison of the transcellular transport of FDG and D-glucose by the kidney epithelial cell line, LLC-PK1.
Kobayashi M; Shikano N; Nishii R; Kiyono Y; Araki H; Nishi K; Oh M; Okudaira H; Ogura M; Yoshimoto M; Okazawa H; Fujibayashi Y; Kawai K
Nucl Med Commun; 2010 Feb; 31(2):141-6. PubMed ID: 19949354
[TBL] [Abstract][Full Text] [Related]
10. Effect of hyperglycemia on in vitro tumor uptake of tritiated FDG, thymidine, L-methionine and L-leucine.
Torizuka T; Clavo AC; Wahl RL
J Nucl Med; 1997 Mar; 38(3):382-6. PubMed ID: 9074524
[TBL] [Abstract][Full Text] [Related]
11. Uptake of [18F]fluorodeoxyglucose in human monocyte-macrophages in vitro.
Deichen JT; Prante O; Gack M; Schmiedehausen K; Kuwert T
Eur J Nucl Med Mol Imaging; 2003 Feb; 30(2):267-73. PubMed ID: 12552345
[TBL] [Abstract][Full Text] [Related]
12. Influence of resistance to 5-fluorouracil and tomudex on [18F]‑FDG incorporation, glucose transport and hexokinase activity.
Law AA; Collie-Duguid ES; Smith TA
Int J Oncol; 2012 Jul; 41(1):378-82. PubMed ID: 22576694
[TBL] [Abstract][Full Text] [Related]
13. [Uptake of FDG (2-fluoro-2-deoxy-D-glucose) as a tumor imaging agent into erythrocytes and accumulation of FDG in tumor cells].
Minosako Y; Nemoto M; Ino S; Shirakami Y; Kurami M
Kaku Igaku; 2003 Feb; 40(1):23-30. PubMed ID: 12701204
[TBL] [Abstract][Full Text] [Related]
14. Dexamethasone treatment and plasma glucose levels: relevance for fluorine-18-fluorodeoxyglucose uptake measurements in gliomas.
Roelcke U; Blasberg RG; von Ammon K; Hofer S; Vontobel P; Maguire RP; Radü EW; Herrmann R; Leenders KL
J Nucl Med; 1998 May; 39(5):879-84. PubMed ID: 9591593
[TBL] [Abstract][Full Text] [Related]
15. Hypoglycemia activates compensatory mechanism of glucose metabolism of brain.
Márián T; Balkay L; Fekete I; Lengyel Z; Veress G; Esik O; Trón L; Krasznai Z
Acta Biol Hung; 2001; 52(1):35-45. PubMed ID: 11396840
[TBL] [Abstract][Full Text] [Related]
16. Characterization of 18F-FDG uptake in human endothelial cells in vitro.
Maschauer S; Prante O; Hoffmann M; Deichen JT; Kuwert T
J Nucl Med; 2004 Mar; 45(3):455-60. PubMed ID: 15001687
[TBL] [Abstract][Full Text] [Related]
17. 2-Deoxy-2-[18F]fluoro-D-glucose positron emission tomography demonstrates target inhibition with the potential to predict anti-tumour activity following treatment with the AKT inhibitor AZD5363.
Maynard J; Ricketts SA; Gendrin C; Dudley P; Davies BR
Mol Imaging Biol; 2013 Aug; 15(4):476-85. PubMed ID: 23344784
[TBL] [Abstract][Full Text] [Related]
18. In vitro 2-deoxy-2-[18F]fluoro-D-glucose uptake: practical considerations.
Mertens K; Mees G; Lambert B; Van de Wiele C; Goethals I
Cancer Biother Radiopharm; 2012 Apr; 27(3):183-8. PubMed ID: 22372557
[TBL] [Abstract][Full Text] [Related]
19. Transport of D-glucose and 2-fluorodeoxyglucose across the blood-brain barrier in humans.
Hasselbalch SG; Knudsen GM; Holm S; Hageman LP; Capaldo B; Paulson OB
J Cereb Blood Flow Metab; 1996 Jul; 16(4):659-66. PubMed ID: 8964806
[TBL] [Abstract][Full Text] [Related]
20. Changes in tumor metabolism as readout for Mammalian target of rapamycin kinase inhibition by rapamycin in glioblastoma.
Wei LH; Su H; Hildebrandt IJ; Phelps ME; Czernin J; Weber WA
Clin Cancer Res; 2008 Jun; 14(11):3416-26. PubMed ID: 18519772
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
